Literature DB >> 17460734

Noninvasive imaging of melanoma with reflectance mode confocal scanning laser microscopy in a murine model.

Daniel S Gareau1, Glenn Merlino, Christopher Corless, Molly Kulesz-Martin, Steven L Jacques.   

Abstract

A reflectance-mode confocal scanning laser microscope (rCSLM) was developed for imaging early-stage melanoma in a living mouse model without the addition of exogenous contrast agents. Lesions were first located by surveying the dorsum with a polarized light camera, then imaged with the rCSLM. The images demonstrated two characteristics of melanoma in this animal model: (1) melanocytes and apparent tumor nests in the epidermis at the stratum spinosum in a state of pagetoid spread and (2) architectural disruption of the dermal-epidermal junction. The epidermal melanocytes and apparent tumor nests had a high melanin content, which caused their reflectance to be fivefold greater than the surrounding epidermis. The rCSLM images illustrate the difference between normal skin and sites with apparent melanoma. This imaging modality shows promise to track the progression of melanoma lesions in animal models.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460734     DOI: 10.1038/sj.jid.5700829

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

1.  Automated detection of malignant features in confocal microscopy on superficial spreading melanoma versus nevi.

Authors:  Dan Gareau; Ricky Hennessy; Eric Wan; Giovanni Pellacani; Steven L Jacques
Journal:  J Biomed Opt       Date:  2010 Nov-Dec       Impact factor: 3.170

Review 2.  Nonlinear absorption microscopy.

Authors:  Tong Ye; Dan Fu; Warren S Warren
Journal:  Photochem Photobiol       Date:  2009-01-23       Impact factor: 3.421

Review 3.  Current and emerging technologies in melanoma diagnosis: the state of the art.

Authors:  Estee L Psaty; Allan C Halpern
Journal:  Clin Dermatol       Date:  2009 Jan-Feb       Impact factor: 3.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.